International Clinical Trial: A Single-center, open-label, single-arm, fixed-sequence, self-controlled study to evaluate the pharmacokinetic effect of Y-3 for injection on rosuvastatin calcium tablets in healthy participants

Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123142) titled 'A Single-center, open-label, single-arm, fixed-sequence, self-controlled study to evaluate the pharmacokinetic effect of Y-3 for injection on rosuvastatin calcium tablets in healthy participants' on April 22.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The First Affiliated Hospital of Bengbu Medical University

Condition: Acute ischemic stroke

Intervention: Single-administration group:On Days 1 and 11 of the trial, subjects shall orally take one tablet (10 mg) of rosuvastatin calcium on an fasted in the morning.

Recruitment Status: Not Recruiting

Phase: N/A

Date of First En...